je.st
news
Daiichi Sankyo Enters Clot Drug Race With Edoxaban Study Success
2013-09-01 22:41:19| Food - Topix.net
Daiichi Sankyo Co.' s experimental blood thinner edoxaban was found to be as effective and safer than standard treatment warfarin in a study that clears the way for the Japanese company to compete with drugmakers including Pfizer Inc., Johnson & Johnson and Bristol-Myers Squibb Co.
Tags: study
success
drug
race
Category:Food and Related Products
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||